[{"orgOrder":0,"company":"Beneo","sponsor":"Beneo","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Inapplicable","moa":"||Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Beneo","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ Beneo"},{"orgOrder":0,"company":"Beneo","sponsor":"German Sport University, Cologne","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"GERMANY","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Inapplicable","moa":"||Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ German Sport University, Cologne","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ German Sport University, Cologne"},{"orgOrder":0,"company":"Beneo","sponsor":"Hospital Universitari Sant Joan de Reus | Hospital de Tarragona Joan XXIII | Institut Investigacio Sanitaria Pere Virgili","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"GERMANY","productType":"Probiotic","year":"2021","type":"Inapplicable","leadProduct":"Inapplicable","moa":"||Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Hospital Universitari Sant Joan de Reus | Hospital de Tarragona Joan XXIII | Institut Investigacio Sanitaria Pere Virgili","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ Hospital Universitari Sant Joan de Reus | Hospital de Tarragona Joan XXIII | Institut Investigacio Sanitaria Pere Virgili"},{"orgOrder":0,"company":"Beneo","sponsor":"University of Reading","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"GERMANY","productType":"Probiotic","year":"2022","type":"Inapplicable","leadProduct":"Inapplicable","moa":"||Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ University of Reading","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ University of Reading"},{"orgOrder":0,"company":"Beneo","sponsor":"Universitair Ziekenhuis Brussel","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"GERMANY","productType":"Probiotic","year":"2023","type":"Inapplicable","leadProduct":"Inapplicable","moa":"||Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ Universitair Ziekenhuis Brussel","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ Universitair Ziekenhuis Brussel"},{"orgOrder":0,"company":"Beneo","sponsor":"BioTeSys GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"GERMANY","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"Isomaltulose","moa":"||Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Beneo","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Beneo \/ BioTeSys GmbH","highestDevelopmentStatusID":"1","companyTruncated":"Beneo \/ BioTeSys GmbH"}]

Find Clinical Drug Pipeline Developments & Deals by Beneo

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Lead Product(s) : Low Glycaemic Index,Inapplicable

                          Therapeutic Area : Undisclosed

                          Study Phase : Undisclosed

                          Sponsor : German Sport University, Cologne

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          May 30, 2023

                          Lead Product(s) : Low Glycaemic Index,Inapplicable

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : German Sport University, Cologne

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Lead Product(s) : New Prebiotic Follow-On Formula,Inapplicable

                          Therapeutic Area : Undisclosed

                          Study Phase : Undisclosed

                          Sponsor : Universitair Ziekenhuis Brussel

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          March 24, 2023

                          Lead Product(s) : New Prebiotic Follow-On Formula,Inapplicable

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Universitair Ziekenhuis Brussel

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          August 29, 2022

                          Lead Product(s) : Isomaltulose,Inapplicable

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Recipient : Swansea University

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          January 28, 2022

                          Lead Product(s) : Prebiotic,Inapplicable

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : University of Reading

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Lead Product(s) : Prebiotic,Inapplicable

                          Therapeutic Area : Undisclosed

                          Study Phase : Undisclosed

                          Sponsor : Hospital Universitari Sant Joan de Reus | Hospital de Tarragona Joan XXIII | Institut Investigacio Sanitaria Pere Virgili

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          March 10, 2021

                          Lead Product(s) : Prebiotic,Inapplicable

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Hospital Universitari Sant Joan de Reus | Hospital de Tarragona Joan XXIII | Institut Investigacio Sanitaria Pere Virgili

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          October 22, 2020

                          Lead Product(s) : Vitalose,Isomaltulose

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : BioTeSys GmbH

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          June 14, 2019

                          Lead Product(s) : Isomaltulose,Inapplicable

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Undisclosed

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          08

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Lead Product(s) : Prebiotic Fructan,Inapplicable

                          Therapeutic Area : Gastroenterology

                          Study Phase : Undisclosed

                          Recipient : Xinhua Hospital, Shanghai Jiaotong University School of Medicine

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          May 08, 2019

                          Lead Product(s) : Prebiotic Fructan,Inapplicable

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Undisclosed

                          Recipient : Xinhua Hospital, Shanghai Jiaotong University School of Medicine

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          09

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Lead Product(s) : Carbohydrate-Based Breakfast,Protein-Based Breakfast

                          Therapeutic Area : Endocrinology

                          Study Phase : Undisclosed

                          Recipient : German Institute of Human Nutrition

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          January 16, 2019

                          Lead Product(s) : Carbohydrate-Based Breakfast,Protein-Based Breakfast

                          Therapeutic Area : Endocrinology

                          Highest Development Status : Undisclosed

                          Recipient : German Institute of Human Nutrition

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          10

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Lead Product(s) : Oligofructose-Enriched Inulin,Inapplicable

                          Therapeutic Area : Gastroenterology

                          Study Phase : Undisclosed

                          Recipient : Children's Hospital of Philadelphia

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          August 31, 2018

                          Lead Product(s) : Oligofructose-Enriched Inulin,Inapplicable

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Undisclosed

                          Recipient : Children's Hospital of Philadelphia

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank